Treatment Modalities and the Impact of Granulocyte Colony-Stimulating Factor in AML Patients Treated With Venetoclax and Azacitidine: A DATAML Registry Study.

Lapierre L, Laemmel L, Bérard E, Rigolot L, Bidet A, Higué J, Banos A, Béziat G, Jeddi R, Branco B, Calmettes C, Gadaud N, Gauthier M, Ghenim L, Laboure G, Salvado C, Tabrizi R, Thomazeau J, Vaillant W, Tavitian S, Balardy L, Leguay T, Canali A, Klein E, Sarry A, Mougenot M, Baraniecki E, de Grande AC, Bories P, Largeaud L, Heiblig M, Belhabri A, Tauveron-Jalenques U, Tavernier E, Carré M, Pigneux A, Vergez F, Bertoli S, Dumas PY, Récher C

Open source

DOI: 10.1016/j.clml.2026.07.007
Published: 2026 Jul 17
Container: Clinical lymphoma, myeloma & leukemia
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.clml.2026.07.007,
  title = {Treatment Modalities and the Impact of Granulocyte Colony-Stimulating Factor in AML Patients Treated With Venetoclax and Azacitidine: A DATAML Registry Study.},
  author = {Lapierre L and Laemmel L and Bérard E and Rigolot L and Bidet A and Higué J and Banos A and Béziat G and Jeddi R and Branco B and Calmettes C and Gadaud N and Gauthier M and Ghenim L and Laboure G and Salvado C and Tabrizi R and Thomazeau J and Vaillant W and Tavitian S and Balardy L and Leguay T and Canali A and Klein E and Sarry A and Mougenot M and Baraniecki E and de Grande AC and Bories P and Largeaud L and Heiblig M and Belhabri A and Tauveron-Jalenques U and Tavernier E and Carré M and Pigneux A and Vergez F and Bertoli S and Dumas PY and Récher C},
  year = {2026},
  journal = {Clinical lymphoma, myeloma \& leukemia},
  doi = {10.1016/j.clml.2026.07.007},
  url = {https://doi.org/10.1016/j.clml.2026.07.007}
}

RIS

TY  - JOUR
TI  - Treatment Modalities and the Impact of Granulocyte Colony-Stimulating Factor in AML Patients Treated With Venetoclax and Azacitidine: A DATAML Registry Study.
AU  - Lapierre L
AU  - Laemmel L
AU  - Bérard E
AU  - Rigolot L
AU  - Bidet A
AU  - Higué J
AU  - Banos A
AU  - Béziat G
AU  - Jeddi R
AU  - Branco B
AU  - Calmettes C
AU  - Gadaud N
AU  - Gauthier M
AU  - Ghenim L
AU  - Laboure G
AU  - Salvado C
AU  - Tabrizi R
AU  - Thomazeau J
AU  - Vaillant W
AU  - Tavitian S
AU  - Balardy L
AU  - Leguay T
AU  - Canali A
AU  - Klein E
AU  - Sarry A
AU  - Mougenot M
AU  - Baraniecki E
AU  - de Grande AC
AU  - Bories P
AU  - Largeaud L
AU  - Heiblig M
AU  - Belhabri A
AU  - Tauveron-Jalenques U
AU  - Tavernier E
AU  - Carré M
AU  - Pigneux A
AU  - Vergez F
AU  - Bertoli S
AU  - Dumas PY
AU  - Récher C
PY  - 2026
JO  - Clinical lymphoma, myeloma & leukemia
DO  - 10.1016/j.clml.2026.07.007
UR  - https://doi.org/10.1016/j.clml.2026.07.007
ER  -

APA

L, L., L, L., E, B., L, R., A, B., J, H., A, B., G, B., R, J., B, B., C, C., N, G., M, G., L, G., G, L., C, S., R, T., J, T., W, V., S, T., L, B., T, L., A, C., E, K., A, S., M, M., E, B., AC, D. G., P, B., L, L., M, H., A, B., U, T., E, T., M, C., A, P., F, V., S, B., PY, D., & C, R. (2026). Treatment Modalities and the Impact of Granulocyte Colony-Stimulating Factor in AML Patients Treated With Venetoclax and Azacitidine: A DATAML Registry Study.. Clinical lymphoma, myeloma & leukemia. https://doi.org/10.1016/j.clml.2026.07.007

Source records

pubmed · retrieved 2026-09-27T07:44:31.991Z